|
Volumn 20, Issue 21, 2012, Pages 6465-6481
|
Potent small molecule Hedgehog agonists induce VEGF expression in vitro
|
Author keywords
Hedgehog; SAG; VEGF
|
Indexed keywords
1,4 DIAMINOCYCLOHEXANE DERIVATIVE;
3 METHYL N [TRANS 4 (METHYLAMINO)CYCLOHEXYL] N (3 PYRIDIN 4 YLBENZYL)BENZO[B] FURAN 2 CARBOXAMIDE 10J;
3 PYRIDIN 4 YLBENZALDEHYDE 17;
ANGIOGENESIS INHIBITOR;
CIS 4 [(TERT BUOXYCARBONYL)(METHYL)AMINO]CYCLOHEXYL BENZOIC ACID;
ETHYL 3 CHLORO 1H INDOLE 2 CARBOXYLIC ACID 20;
SAG DERIVA TIVE;
SONIC HEDGEHOG PROTEIN;
TERT BUTYL (CIS 4 AZIDOCYCLOHEXYL)METHYLCARBAMIC ACID 7;
TERT BUTYL (CIS 4 HYDOXYCYCLOHEXYL)METHYLCARBAMIC ACID 5;
TERT BUTYL (TRANS 4 AMINOCYCLOHEXYL)METHYLCARBAMIC ACID 1A;
TERT BUTYL (TRANS 4 AMINOCYCLOHEXYL)METHYLCARBAMIC ACID 1B;
TERT BUTYL (TRANS 4 AZIDOCYCLOHEXYL)METHYLCARBAMIC ACID 6;
TERT BUTYL (TRANS 4 HYDROXYCYCLOHEXYL)METHYLCARBAMIC ACID;
TERT BUTYL 4 AMINOPIPERIDINE 1 CARBOXYLIC ACID 11;
TERT BUTYL [CIS 4 [[(3 CHLOROBENZO[B]THIOPHENE 2 YL)CARBONYL] (3 PYRIDIN 4 YL BENZYL)AMINO]CYCLOHEXYL]METHYLCARBAMIC ACID 9E;
TERT BUTYL [CIS 4 [[(3,4 DICHLOROBENZO[B]THIOPHENE 2 YL)CARBONYL] (3 PYRIDIN 4 YL BENZYL)AMINO]CYCLOHEXYL]METHYLCARBAMIC ACID 9B;
TERT BUTYL [CIS 4 [[(3,4 DICHLOROBENZO[B]THIOPHENE 2 YL)CARBONYL] (3 PYRIDIN 4 YL BENZYL)AMINO]CYCLOHEXYL]METHYLCARBAMIC ACID 9C;
TERT BUTYL [TRANS 4 [[(3 CHLORO 6 FLUOROBENZO[B]THIOPHENE 2 YL)CARBONYL] (3 PYRIDIN 4 YLBENZYL)AMINO]CYCLOHEXYL]METHYLCARBAMIC ACID 9G;
TERT BUTYL [TRANS 4 [[(3 CHLOROBENZO[B]THIOPHENE 2 YL)CARBONYL] (3 PYRIDIN 4 YL BENZYL)AMINO]CYCLOHEXYL]METHYLCARBAMIC ACID 9A;
TERT BUTYL [TRANS 4 [[(3,4 DICHLOROBENZO[B]THIOPHENE 2 YL)CARBONYL] (3 PYRIDIN 4 YL BENZYL)AMINO]CYCLOHEXYL]METHYLCARBAMIC ACID 9C;
TERT BUTYL [TRANS 4 [[(3,6 DICHLOROBENZO[B]THIOPHENE 2 YL)CARBONYL] (3 PYRIDIN 4 YLBENZYL)AMINO]CYCLOHEXYL]METHYLCARBAMIC ACID 9H;
TERT BUTYL METHYL [CIS 4 [(3 PYRIDIN 4 YLBENZYL)AMINO]CYCLOHEXYL]CARBAMIC ACID 8B;
TERT BUTYL METHYL [TRANS 4 [(3 PYRIDIN 4 YLBENZYL)AMINO]CYCLOHEXYL]CARBAMIC ACID 8A;
TERT BUTYL METHYL [TRANS 4 [(5 PHENYL 2 FUROYL) (3 PYRIDIN 4 YLBENZYL)AMINO]CYCLOHEXYL]CARBAMIC ACID 9D;
TERT BUTYL METHYL [TRANS 4 [(PYRIDIN 4 YLMETHYL)AMINO]CYCLOHEXYL]CARBAMIC ACID 8D;
TERT BUTYL METHYL [TRANS 4 [(QUINOLIN 4 YLMETHYL)AMINO]CYCLOHEXYL]CARBAMIC ACID 8C;
TRANSCRIPTION FACTOR GLI1;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VASCULOTROPIN;
ACYLATION;
AMINATION;
ANTIANGIOGENIC ACTIVITY;
ARTICLE;
CARBON NUCLEAR MAGNETIC RESONANCE;
CONTROLLED STUDY;
CYTOTOXICITY;
DEPROTECTION REACTION;
DRUG SYNTHESIS;
FIBROBLAST;
GENE EXPRESSION;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
PROTEIN EXPRESSION;
PROTON NUCLEAR MAGNETIC RESONANCE;
REPORTER GENE;
SIGNAL TRANSDUCTION;
STRUCTURE ACTIVITY RELATION;
ULTRASOUND;
ANIMALS;
CELL PROLIFERATION;
CELL SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENDOTHELIAL CELLS;
HEDGEHOG PROTEINS;
HUMANS;
MOLECULAR STRUCTURE;
SIGNAL TRANSDUCTION;
SMALL MOLECULE LIBRARIES;
STRUCTURE-ACTIVITY RELATIONSHIP;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
ERINACEIDAE;
|
EID: 84867575656
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2012.08.026 Document Type: Article |
Times cited : (20)
|
References (35)
|